慢性乙型肝炎患者肝脏脂肪变性无创诊断方法的研究进展
Research Progress of Non-Invasive Diagnostic Methods for Hepatic Steatosis in Patients with Chronic Hepatitis B
DOI: 10.12677/ACM.2022.1281068, PDF,   
作者: 鲁景楠, 李建龙*:延安大学附属医院,陕西 延安
关键词: 乙型肝炎病毒脂肪变性无创诊断Hepatitis B Virus Steatosis Non-Invasive Diagnosis
摘要: 乙型肝炎病毒(HBV)感染是一个严重的全球性公共卫生问题,是导致全球肝硬化和肝细胞癌的主要病因。随着肥胖和代谢综合征的全球流行,非酒精性脂肪性肝病(NAFLD)成为西方和东方人群中慢性肝病的主要原因。HBV感染与NAFLD并存已成为肝病的普遍现象。肝脏脂肪变性的存在会影响慢性乙肝患者抗病毒治疗的效果,并增加发展为肝硬化和肝细胞癌的风险。因此,检测和量化肝脏脂肪变性对慢性乙肝的诊疗具有重要的意义。肝活检是评估肝脂肪变性的金标准,但由于其侵袭性和并发症的限制,并未在临床得到广泛应用。所以,慢性乙型肝炎患者肝脏脂肪变性的无创诊断就显得尤为重要,该文总结了慢性乙型肝炎患者合并肝脏脂肪变性无创诊断方法的研究进展。
Abstract: Hepatitis B virus (HBV) infection is a serious global public health problem and the main cause of liver cirrhosis and hepatocellular carcinoma in the world. With the global prevalence of obesity and metabolic syndrome, non-alcoholic fatty liver disease (NAFLD) has become the main cause of chron-ic liver disease in western and eastern populations. The coexistence of HBV infection and NAFLD has become a common phenomenon of liver disease. The presence of hepatic steatosis affects the effica-cy of antiviral therapy in patients with chronic hepatitis B and increases the risk of developing cir-rhosis and hepatocellular carcinoma. Therefore, the detection and quantification of hepatic steato-sis is of great significance for the diagnosis and treatment of chronic hepatitis B. Liver biopsy is the gold standard for the evaluation of hepatic steatosis, but it has not been widely used in clinic be-cause of its invasiveness and complications. Therefore, the non-invasive diagnosis of hepatic steato-sis in patients with chronic hepatitis B is particularly important. This paper summarizes the re-search progress of non-invasive diagnosis of hepatic steatosis in patients with chronic hepatitis B.
文章引用:鲁景楠, 李建龙. 慢性乙型肝炎患者肝脏脂肪变性无创诊断方法的研究进展[J]. 临床医学进展, 2022, 12(8): 7400-7404. https://doi.org/10.12677/ACM.2022.1281068

参考文献

[1] MacLachlan, J.H. and Cowie, B.C. (2015) Hepatitis B Virus Epidemiology. Cold Spring Harbor Perspectives in Biology, 5, Article ID: a021410. [Google Scholar] [CrossRef] [PubMed]
[2] Younossi, Z.M., Koenig, A.B., Abdelatif, D., Fazel, Y., Henry, L. and Wymer, M. (2016) Global Epidemiology of Nonalcoholic Fatty Liver Dis-ease-Meta-Analytic Assessment of Prevalence, Incidence, and Outcomes. Hepatology, 64, 73-84. [Google Scholar] [CrossRef] [PubMed]
[3] Petta, S., Muratore, C. and Craxì, A. (2009) Non-Alcoholic Fatty Liver Disease Pathogenesis: The Present and the Future. Digestive and Liver Disease, 41, 615-625. [Google Scholar] [CrossRef] [PubMed]
[4] Machado, M.V., Oliveira, A.G. and Cortez-Pinto, H. (2011) Hepat-icsteatosis in Hepatitis B Virus Infected Patients: Meta-Analysis of Risk Factors and Comparison with Hepatitis C In-fected Patients. Journal of Gastroenterology and Hepatology, 26, 1361-1367. [Google Scholar] [CrossRef] [PubMed]
[5] Spradling, P.R., Bulkow, L., Teshale, E.H., Negus, S., Homan, C., Simons, B., et al. (2014) Prevalence and Causes of Elevated Serum Aminotransferase Levels in a Popula-tion-Based Cohort of Persons with Chronic Hepatitis B Virus Infection. Journal of Hepatology, 61, 785-791. [Google Scholar] [CrossRef] [PubMed]
[6] Jin, X., Chen, Y.P., Yang, Y.D., Li, Y.M., Zheng, L. and Xu, C.Q. (2012) Association between Hepatic Steatosis and Entecavir Treatment Failure in Chinese Patients with Chronic Hepatitis B. PLOS ONE, 7, Article ID: e34198. [Google Scholar] [CrossRef] [PubMed]
[7] Chen, Y., Fan, C., Chen, Y., Liu, H., Wang, S., Dong, P., Li, L. and Ding, H. (2017) Effect of Hepatic Steatosis on the Progression of Chronic Hepatitis B: A Prospective Cohort and in Vitro Study. Oncotarget, 8, 58601-58610. [Google Scholar] [CrossRef] [PubMed]
[8] Bravo, A. A., Sheth, S. G. and Chopra, S. (2001) Liver Biopsy. The New England Journal of Medicine, 344, 495-500. [Google Scholar] [CrossRef
[9] Davison, B.A., Harrison, S.A., Cotter, G., Alkhouri, N., Sanyal, A., Edwards, C., et al. (2020) Suboptimal Reliability of Liver Biopsy Evaluation Has Implications for Random-ized Clinical Trials. Journal of Hepatology, 73, 1322-1332. [Google Scholar] [CrossRef] [PubMed]
[10] Lee, J.H., Kim, D., Kim, H.J., Lee, C.H., Yang, J.I., Kim, W., et al. (2010) Hepatic Steatosis Index: A Simple Screening Tool Reflecting Nonalcoholic Fatty Liver Disease. Digestive and Liver Disease, 42, 503-508. [Google Scholar] [CrossRef] [PubMed]
[11] Xu, L., Lu, W., Li, P., Shen, F., Mi, Y.Q. and Fan, J.G. (2017) A Comparison of Hepatic Steatosis Index, Controlled Attenuation Parameter and Ultrasound as Noninvasive Diagnostic Tools for Steatosis in Chronic Hepatitis B. Digestive and Liver Disease, 49, 910-917. [Google Scholar] [CrossRef] [PubMed]
[12] Chang, J.W., Lee, H.W., Kim, B.K., Park, J.Y., Kim, D.Y., Ahn, S.H., Han, K.H. and Kim, S.U. (2021) Hepatic Steatosis Index in the Detection of Fatty Liver in Patients with Chronic Hepatitis B Receiving Antiviral Therapy. Gut and Liver, 15, 117-127. [Google Scholar] [CrossRef] [PubMed]
[13] Ou, H., Cai, S., Liu, Y., Xia, M. and Peng, J. (2017) A Noninvasive Diagnostic Model to Assess Nonalcoholic Hepatic Ste-atosis in Patients with Chronic Hepatitis B. Therapeutic Advances in Gastroenterology, 10, 207-217. [Google Scholar] [CrossRef
[14] Hernaez, R. Lazo, M., Bonekamp, S., Kamel, I., Brancati, F.L., Guallar, E. and Clark, J.M. (2011) Diagnostic Accuracy and Reliability of Ultrasonography for the Detection of Fatty Liver: A Meta-Analysis. Hepatology, 54, 1082-1090. [Google Scholar] [CrossRef] [PubMed]
[15] Bohte, A.E., van Werven, J.R., Bipat, S. and Stoker, J. (2011) The Diag-nostic Accuracy of US CT, MRI and 1H-MRS for the Evaluation of Hepatic Steatosis Compared with Liver Biopsy: A Meta-Analysis. European Radiology, 21, 87-97. [Google Scholar] [CrossRef] [PubMed]
[16] Bril, F., Ortiz-Lopez, C., Lomonaco, R., Orsak, B., Freckleton, M., Chintapalli, K., et al. (2015) Clinical Value of Liver Ultrasound for the Diagnosis of Nonalcoholic Fatty Liver Disease in Overweight and Obese Patients. Liver International, 35, 2139-2146. [Google Scholar] [CrossRef] [PubMed]
[17] Strauss, S., Gavish, E., Gottlieb, P. and Katsnelson, L. (2007) Interobserver and Intraobserver Variability in the Sonographic As-sessment of Fatty Liver. American Journal of Roentgenology, 189, W320-W323. [Google Scholar] [CrossRef
[18] Karlas, T., Petroff, D., Sasso, M., Fan, J.G., Mi, Y.Q., de Lédinghen, V., Kumar, M., Lupsor-Platon, M., Han, K.H., Cardoso, A.C., Ferraioli, G., Chan, W.K., Wong, V.W., Myers, R.P., Cha-yama, K., Friedrich-Rust, M., Beaugrand, M., Shen, F., Hiriart, J.B., Sarin, S.K., Badea, R., Jung, K.S., Marcellin, P., Filice, C., Mahadeva, S., Wong, G.L., Crotty, P., Masaki, K., Bojunga, J., Bedossa, P., Keim, V. and Wiegand, J. (2017) Individual Patient Data Meta-Analysis of Controlled Attenuation Parameter (CAP) Technology for Assessing Steatosis. Journal of Hepatology, 66, 1022-1030. [Google Scholar] [CrossRef] [PubMed]
[19] Ferraioli, G., Tinelli, C., Lissandrin, R., Zicchetti, M., Rondanelli, M., Perani, G., Bernuzzi, S., Salvaneschi, L. and Filice, C. (2014) Interobserver Reproducibility of the Controlled Atten-uation Parameter (CAP) for Quantifying Liver Steatosis. Hepatology International, 8, 576-581. [Google Scholar] [CrossRef] [PubMed]
[20] Castera, L., Friedrich-Rust, M. and Loomba, R. (2019) Noninva-sive Assessment of Liver Disease in Patients with Nonalcoholic Fatty Liver Disease. Gastroenterology, 156, 1264-1281.e4. [Google Scholar] [CrossRef] [PubMed]
[21] de Lédinghen, V., Vergniol, J., Capdepont, M., Chermak, F., Hiriart, J.B., Cassinotto, C., Merrouche, W., Foucher, J. and Brigitte le, B. (2014) Controlled attenuation parameter (CAP) for the Diagnosis of Steatosis: A Prospective Study of 5323 Examinations. Journal of Hepatology, 60, 1026-1031. [Google Scholar] [CrossRef] [PubMed]
[22] Permutt, Z., Le, T.A., Peterson, M.R., Seki, E., Bren-ner, D.A., Sirlin, C. and Loomba, R. (2012) Correlation between Liver Histology and Novel Magnetic Resonance Imag-ing in Adult Patients with Non-Alcoholic Fatty Liver Disease-MRI Accurately Quantifies Hepatic Steatosis in NAFLD. Alimentary Pharmacology & Therapeutics, 36, 22-29. [Google Scholar] [CrossRef] [PubMed]
[23] Tang, A., Desai, A., Hamilton, G., Wolfson, T., Gamst, A., Lam, J., Clark, L., Hooker, J., Chavez, T., Ang, B.D., Middleton, M.S., Peterson, M., Loomba, R. and Sirlin, C.B. (2015) Accuracy of MR Imaging-Estimated Proton Density Fat Fraction for Classification of Dichotomized Histologic Steatosis Grades in Nonalcoholic Fatty Liver Disease. Radiology, 274, 416-425. [Google Scholar] [CrossRef] [PubMed]
[24] Imajo, K., Kessoku, T., Honda, Y., Tomeno, W., Ogawa, Y., Mawa-tari, H., Fujita, K., Yoneda, M., Taguri, M., Hyogo, H., Sumida, Y., Ono, M., Eguchi, Y., Inoue, T., Yamanaka, T., Wa-da, K., Saito, S. and Nakajima, A. (2016) Magnetic Resonance Imaging More Accurately Classifies Steatosis and Fibro-sis in Patients with Nonalcoholic Fatty Liver Disease than Transient Elastography. Gastroenterology, 150, 626-637.e7. [Google Scholar] [CrossRef] [PubMed]
[25] 杨逸铭, 刘玉品, 黄丽霞, 陈志远, 欧阳舒曼, 彭静. 磁共振质子密度脂肪分数和瞬时弹性成像对慢性乙型肝炎患者肝脂肪含量的定量评估价值[J]. 临床肝胆病杂志, 2021, 37(12): 2793-2797.